(Q44938062)

English

Long-term survival benefit and improved complete cytogenetic and molecular response rates with imatinib mesylate in Philadelphia chromosome-positive chronic-phase chronic myeloid leukemia after failure of interferon-alpha

scientific article

Statements

Long-term survival benefit and improved complete cytogenetic and molecular response rates with imatinib mesylate in Philadelphia chromosome-positive chronic-phase chronic myeloid leukemia after failure of interferon-alpha (English)
15 June 2004
1979-1988

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit